Abiomed (FRA:AIO) Cash-to-Debt : No Debt ⁽¹⁾ (As of Sep. 2022)

View and export this data going back to 1987. Start your Free Trial

What is Abiomed Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Abiomed's cash to debt ratio for the quarter that ended in Sep. 2022 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Abiomed could pay off its debt using the cash in hand for the quarter that ended in Sep. 2022.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Abiomed's Cash-to-Debt or its related term are showing as below:

FRA:AIO' s Cash-to-Debt Range Over the Past 10 Years
Min: 13.95 Med: No Debt Max: No Debt
Current: No Debt

During the past 13 years, Abiomed's highest Cash to Debt Ratio was No Debt. The lowest was 13.95. And the median was No Debt.

FRA:AIO's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.875 vs FRA:AIO: No Debt

Abiomed Cash-to-Debt Historical Data

The historical data trend for Abiomed's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Abiomed Cash-to-Debt Chart

Abiomed Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

Abiomed Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Abiomed's Cash-to-Debt

For the Medical Devices subindustry, Abiomed's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abiomed's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abiomed's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Abiomed's Cash-to-Debt falls into.

Abiomed Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Abiomed's Cash to Debt Ratio for the fiscal year that ended in Mar. 2022 is calculated as:

Abiomed had no debt ⁽¹⁾.

Abiomed's Cash to Debt Ratio for the quarter that ended in Sep. 2022 is calculated as:

Abiomed had no debt ⁽¹⁾.

Abiomed (FRA:AIO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Abiomed Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Abiomed's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Abiomed (FRA:AIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abiomed Inc (FRA:AIO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Cherry Hill Drive, Danvers, MA, USA, 01923

Website

https://www.abiomed.com

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.